“肾小保”AI智能体构建三医协同慢病管理新生态

Core Insights - The "Kidney Small Guardian" project, developed by Laolai Health Technology Group, has been recognized as the first AI intelligent management tool for kidney disease by the National Medical Insurance Administration, showcasing a new ecosystem of collaboration among insurance, healthcare, and patients through a SaaS model [1][2] Group 1: Project Overview - The project emerged from a pilot at Shaoyang Central Hospital and was selected from 75 national candidates, indicating its innovative approach to chronic disease management [1] - The SaaS software has successfully managed 159 peritoneal dialysis patients since its launch in October 2025, significantly improving patient satisfaction and resource allocation efficiency in kidney disease management [2] Group 2: Advantages and Future Prospects - The SaaS model offers three main advantages: lightweight deployment reducing digital transformation costs for healthcare institutions, real-time data collaboration among insurance, healthcare, and patients, and strong scalability for extending the model to other chronic diseases like diabetes and hypertension [2] - Laolai Health has served over 34 million users and connected with 10 provincial medical insurance systems, covering over 200 million elderly individuals in China, indicating a strong market presence and potential for further growth in chronic disease management [2]